Cargando…
A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission
Autores principales: | Gremida, Anas, Deepak, Parakkal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802407/ https://www.ncbi.nlm.nih.gov/pubmed/36776653 http://dx.doi.org/10.1093/crocol/otab036 |
Ejemplares similares
-
Induction of Remission in Pediatric Crohn’s Disease Patients Assessed by the Mucosal Inflammation Noninvasive Index
por: Herman, Roma, et al.
Publicado: (2021) -
Exploring the concept of deep remission in Crohn’s disease: correlation between transmural healing and biomarkers
por: Castiglione, Fabiana, et al.
Publicado: (2022) -
Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease
por: Sollelis, Elisa, et al.
Publicado: (2019) -
Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery
por: Mondot, S, et al.
Publicado: (2016) -
Crohn’s disease in remission or simply smouldering?
por: Gaya, Daniel R.
Publicado: (2015)